Geode Capital Management
CNTX icon

Geode Capital Management’s Context Therapeutics CNTX Stock Holding History

Geode Capital Management’s Portfolio CNTX Stock Details CNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.01M Buy
1,830,309
+1,226,542
+203% +$2.49M ﹤0.01% 3362
2026
Q1 		$1.58M Sell
603,767
-4,695
-0.8% -$11K ﹤0.01% 3212
2025
Q4 		$895K Sell
608,462
-115
-0% -$134 ﹤0.01% 3416
2025
Q3 		$590K Sell
608,577
-29,233
-5% -$23.7K ﹤0.01% 3557
2025
Q2 		$418K Sell
637,810
-1,409
-0.2% -$1.01K ﹤0.01% 3609
2025
Q1 		$391K Buy
639,219
+10,490
+2% +$9.13K ﹤0.01% 3637
2024
Q4 		$661K Buy
628,729
+52,830
+9% +$91.4K ﹤0.01% 3514
2024
Q3 		$1.13M Sell
575,899
-42,275
-7% -$93.8K ﹤0.01% 3312
2024
Q2 		$1.24M Buy
618,174
+517,102
+512% +$891K ﹤0.01% 3232
2024
Q1 		$140K Buy
101,072
+3,832
+4% +$4.31K ﹤0.01% 4047
2023
Q4 		$110K Hold
97,240
– – ﹤0.01% 4158
2023
Q3 		$147K Sell
97,240
-9,994
-9% -$11.3K ﹤0.01% 4103
2023
Q2 		$172K Buy
107,234
+47,666
+80% +$40.6K ﹤0.01% 4107
2023
Q1 		$33.5K Sell
59,568
-1,634
-3% -$1.24K ﹤0.01% 4607
2022
Q4 		$40K Buy
61,202
+2,530
+4% +$2.73K ﹤0.01% 4652
2022
Q3 		$65K Hold
58,672
– – ﹤0.01% 4704
2022
Q2 		$124K Buy
58,672
+8,760
+18% +$16.4K ﹤0.01% 4496
2022
Q1 		$108K Buy
+49,912
New +$105K ﹤0.01% 4634

Other funds holding CNTX

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Geode Capital Management's CNTX Position: Q2 2026 in Review

Geode Capital Management increased its Context Therapeutics (CNTX) stake by 203% in Q2 2026, buying an estimated $2.49M and bringing the position to 1,830,309 shares worth $1.01M. The position accounts for ﹤0.01% of the portfolio, ranked #3362.

Geode Capital Management first reported a position in CNTX in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.58M in Q1 2026. 79 funds tracked by Wall St. Rank hold CNTX as of Q2 2026.

  • Geode Capital Management held 1,830,309 shares of Context Therapeutics worth $1.01M as of Q2 2026.
  • Geode Capital Management bought 1,226,542 Context Therapeutics shares in Q2 2026, an estimated $2.49M.
  • Context Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3362 holding.
  • Geode Capital Management first reported a position in Context Therapeutics in Q1 2022 and has held it in 18 quarters since.
  • Geode Capital Management's Context Therapeutics position peaked at $1.58M in Q1 2026.
  • 79 funds tracked by Wall St. Rank held Context Therapeutics as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.